the effect of fennel on quality of life and sleep quality

Comparison of Foeniculum Vulgare and placebo for sleep quality and quality of life in menopausal women

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016092828789N3

Enrollment

Registered

2017-06-15

Start date

2015-06-14

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: quality of life in postmenopausal women. Condition 2: Quality of life. Menopausal and female climacteric States Sleep Disorder, Unspecified

Interventions

Intervention 1: 100-mg soft capsules containing 30% fennel (Standardized to 21-27 mg anethole), three times a day, for three months. Intervention 2: 100-mg soft capsules containing sunflower oil, thre

Treatment - Drugs

100-mg soft capsules containing 30% fennel (Standardized to 21-27 mg anethole), three times a day, for three months

100-mg soft capsules containing sunflower oil, three times a day, for three months

Eligibility

Sex/Gender

Female

Age

44 Years to 64 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Healthy postmenopausal women aged 45 to 65 with no vaginal bleeding for one year; a normal mammogram in the last year Exclusion criteria: use of systemic and tropical estrogen in past six months.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Attitude toward to menopause questionnaire. Timepoint: before intervention and 90 days after intervention. Method of measurement: Attitude toward to menopause questionnaire.;Anxiety and depression. Timepoint: before intervention and 90 days after intervention. Method of measurement: Hospital Anxiety and Depression Scale (HADS).;Sleep quality. Timepoint: before intervention and 90 days after intervention. Method of measurement: Pittsburgh Sleep Quality Index.;The Menopause-Specific Quality of Life (MENQOL). Timepoint: before intervention and 90 days after intervention. Method of measurement: The Menopause-Specific Quality of Life (MENQOL) Questionnaire.	—

Measure

Time frame

Attitude toward to menopause questionnaire. Timepoint: before intervention and 90 days after intervention. Method of measurement: Attitude toward to menopause questionnaire.;Anxiety and depression. Timepoint: before intervention and 90 days after intervention. Method of measurement: Hospital Anxiety and Depression Scale (HADS).;Sleep quality. Timepoint: before intervention and 90 days after intervention. Method of measurement: Pittsburgh Sleep Quality Index.;The Menopause-Specific Quality of Life (MENQOL). Timepoint: before intervention and 90 days after intervention. Method of measurement: The Menopause-Specific Quality of Life (MENQOL) Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Tafaghodi

Mashhad University of Medical Sciences

Tafaghodim@mums.ac.ir+98 51 3843 7840

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026